SRTD Raises 31 Point 5 Million Euros for Selective RNA

Recovered source-gap item: SRTD Biotech completed an oversubscribed €31.5 million seed round announced November 9 to advance selectively expressed mRNA constructs toward IND-enabling work. The separately reported CEO appointment is assessed in its own…




